Brief: Herantis Pharma wins EUR 6.0 million grant for Parkinson study

Herantis Pharma Oyj

12/12/2016 07:00

Dec 12 (Reuters) - Herantis Pharma Oyj  HRTIS.HE : 
    * Says its Parkinson study wins 6.0 million euros grant from European Union Horizon 2020 
Program 
    * Grant is for phase 1-2 clinical study 
    * Expects its financial position to remain positive until end of 2018 (previously estimated: 
end of 2017) 
 
Source text for Eikon:  ID:nGNE7ngP6s  
Further company coverage:  HRTIS.HE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))